Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
---|
12/07/2000 | WO2000073451A1 Mammalian receptor proteins; related reagents and methods |
12/07/2000 | WO2000073450A2 Cytoskeleton-associated proteins |
12/07/2000 | WO2000073449A1 Dna encoding snorf33 receptor |
12/07/2000 | WO2000073448A1 Adipocyte complement related protein homolog zacrp7 |
12/07/2000 | WO2000073445A2 Interleukin-1-receptor associated kinase-3 (irak3) |
12/07/2000 | WO2000073444A1 Adipocyte complement related protein homolog zacrp5 |
12/07/2000 | WO2000073443A1 Lipid metabolism transcription factor |
12/07/2000 | WO2000073440A1 Pollinosis-associated gene 787 |
12/07/2000 | WO2000073432A2 Activation of dendritic cells to enhance immunity |
12/07/2000 | WO2000073431A2 Methods and compositions for measuring ion channel conductance |
12/07/2000 | WO2000073424A1 A novel baculovirus/adenovirus hybrid vector for the rescue, production and titration of high-capacity adenovirus amplicon vectors |
12/07/2000 | WO2000073423A1 Packaging cell |
12/07/2000 | WO2000073422A1 Genetically modified plant cells and plants with an increased activity of an amylosucrase protein and a branching enzyme |
12/07/2000 | WO2000073421A2 Methods of isolation, cryopreservation, and therapeutic use of human amniotic epithelial cells |
12/07/2000 | WO2000073419A1 Immortalized human middle ear epithelial cell lines |
12/07/2000 | WO2000073418A2 A method of using autologous fibroblasts to promote healing of wounds and fistulas |
12/07/2000 | WO2000073417A1 In vitro cell culture device including cartilage and methods of using the same |
12/07/2000 | WO2000073416A1 Antisense oligonucleotides for fertility and menstrual cycle regulation and for chemopreventive and chemotherapeutic use |
12/07/2000 | WO2000073415A2 A method for the transfer of antigens to dendritic cells |
12/07/2000 | WO2000073411A1 Multi- applicable cell-culture method and apparatus |
12/07/2000 | WO2000073349A1 Dr4 antibodies and uses thereof |
12/07/2000 | WO2000073348A2 Methods and compositions for inhibiting neoplastic cell growth |
12/07/2000 | WO2000073344A2 Monoclonal antibodies, synthetic and biotechnological derivatives thereof acting as ngf-antagonist molecules |
12/07/2000 | WO2000073338A1 Compositions and methods for the therapy, diagnosis and monitoring of breast cancer |
12/07/2000 | WO2000073335A1 Cytotoxic t-cell epitopes of the papilloma virus l1-protein and use thereof in diagnosis and therapy |
12/07/2000 | WO2000073334A2 Human sorting nexins |
12/07/2000 | WO2000073324A2 Modulation of gene expression in gastrointestinal inflammation |
12/07/2000 | WO2000073323A2 Adam polynucleotides and polypeptides |
12/07/2000 | WO2000073321A1 Human tumor necrosis factor receptor tr10 |
12/07/2000 | WO2000073319A1 Method for enhanced protein stabilization and production of cell lines useful for production of such stabilized proteins |
12/07/2000 | WO2000072895A1 Cell-coated supports |
12/07/2000 | WO2000072887A1 A novel packaging cell line for the rescue, production and titration of high-capacity adenovirus amplicon vectors |
12/07/2000 | WO2000072885A2 Methods of inducing regulated pancreatic hormone production in non-pancreatic islet tissues |
12/07/2000 | WO2000072666A2 USE OF TRANSGENIC MICE LACKING JunB EXPRESSION IN THE MYELOID LINEAGE |
12/07/2000 | WO2000050568A3 Transplantation of haematopoietic cells |
12/07/2000 | WO2000050565A3 Compositions, kits, and methods relating to the human fez1 gene, a novel tumor suppressor gene |
12/07/2000 | WO2000047727A3 Nucleic acid molecules encoding alternansucrase |
12/07/2000 | WO2000046391A3 Genes displaying enhanced expression during cellular senescence and terminal cell differentiation and uses thereof |
12/07/2000 | WO2000043519A3 Neisseria meningitidis polypeptides |
12/07/2000 | WO2000043500A3 Immortalized cell lines and methods of making the same |
12/07/2000 | WO2000042561A3 Oligonucleotide mediated nucleic acid recombination |
12/07/2000 | WO2000042205A3 Herbicide target gene and methods |
12/07/2000 | WO2000039304A9 Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof |
12/07/2000 | WO2000038708A9 Treatment and prevention of immune rejection reactions |
12/07/2000 | WO2000032140A9 System and sequential culture media for in vitro fertilization |
12/07/2000 | WO2000031247A3 Recombinant methods and materials for producing epothilone and epothilone derivatives |
12/07/2000 | DE19925235A1 Zytotoxische T-Zellepitope des Papillomavirus L1-Proteins und ihre Verwendung in Diagnostik und Therapie Cytotoxic T cell epitopes of the papillomavirus L1 protein and its use in diagnosis and therapy |
12/07/2000 | DE19925199A1 Zytotoxische T-Zellepitope des Papillomavirus L1-Proteins und ihre Verwendung in Diagnostik und Therapie Cytotoxic T cell epitopes of the papillomavirus L1 protein and its use in diagnosis and therapy |
12/07/2000 | CA2725132A1 Method for separating cells using immunorosettes |
12/07/2000 | CA2414214A1 Four-helical bundle protein zsig81 |
12/07/2000 | CA2383244A1 Protein kinases |
12/07/2000 | CA2378737A1 Adipocyte complement related protein homolog zacrp5 |
12/07/2000 | CA2376116A1 Promotion or inhibition of angiogenesis and cardiovascularization |
12/07/2000 | CA2375888A1 Cytotoxic t-cell epitopes of the papillomavirus l1-protein and use thereof in diagnostics and therapy |
12/07/2000 | CA2375873A1 Methods and compositions for isolating high molecular weight dna from natural samples |
12/07/2000 | CA2375855A1 Modulation of gene expression in gastrointestinal inflammation |
12/07/2000 | CA2375802A1 Cytotoxic t-cell epitopes of the papilloma virus l1-protein and use thereof in diagnosis and therapy |
12/07/2000 | CA2375349A1 A method for the transfer of antigens to dendritic cells |
12/07/2000 | CA2375209A1 Multi-applicable cell-culture method and apparatus |
12/07/2000 | CA2375123A1 Use of recombinant gene delivery vectors for treating or preventing lysosomal storage disorders |
12/07/2000 | CA2375106A1 Compositions and methods for the therapeutic use of an atonal-associated sequence for deafness, osteoarthritis, and abnormal cell proliferation |
12/07/2000 | CA2375095A1 Groel muteins with improved stability |
12/07/2000 | CA2375050A1 T-bet compositions and methods of use thereof |
12/07/2000 | CA2375049A1 Compositions and methods for the therapy, diagnosis and monitoring of breast cancer |
12/07/2000 | CA2375047A1 Dna encoding snorf33 receptor |
12/07/2000 | CA2374599A1 Dr4 antibodies and uses thereof |
12/07/2000 | CA2374597A1 Methods and compositions for lowering the level of tumor necrosis factor (tnf) in the tnf-associated disorders |
12/07/2000 | CA2374412A1 Secreted alpha-helical protein-31 |
12/07/2000 | CA2374391A1 Mammalian receptor proteins; related reagents and methods |
12/07/2000 | CA2374387A1 Adipocyte complement related protein homolog zacrp7 |
12/07/2000 | CA2374376A1 Lipid metabolism transcription factor |
12/07/2000 | CA2374222A1 Cytoskeleton-associated proteins |
12/07/2000 | CA2373915A1 Methods and compositions for inhibiting neoplastic cell growth |
12/07/2000 | CA2373638A1 Adam polynucleotides and polypeptides |
12/07/2000 | CA2372246A1 Human tumor necrosis factor receptor tr10 |
12/07/2000 | CA2372243A1 Method for enhanced protein stabilization and production of cell lines useful for production of such stabilized proteins |
12/07/2000 | CA2371995A1 Methods of inducing regulated pancreatic hormone production in non-pancreatic islet tissues |
12/07/2000 | CA2336262A1 Sorting nexins |
12/06/2000 | EP1057891A1 Use of the BNM3 transcriptional activator to control plant embryogenesis and regeneration processes |
12/06/2000 | EP1057890A1 Monoclonal antibody for immunologically analyzing or concentrating endocrine disrupting substance or its degradation product and utilization of the same |
12/06/2000 | EP1056886A1 Hla linked pre-eclampsia and miscarriage susceptibility gene |
12/06/2000 | EP1056880A1 Methods for purified aav vector production |
12/06/2000 | EP1056878A1 Artificial chromosome constructs containing nucleic acid sequences capable of directing the formation of a recombinant virus |
12/06/2000 | EP1056877A1 Self-regulated apoptosis of inflammatory cells by gene therapy |
12/06/2000 | EP1056871A1 Cprot03, a human cysteine protease |
12/06/2000 | EP1056869A2 Cell cycle related proteins |
12/06/2000 | EP1056868A1 Human homolog of the drosophila protein 'fused' |
12/06/2000 | EP1056866A1 CULTIVAR SPECIFICITY GENE FROM THE RICE PATHOGEN $i(MAGNAPORTHE GRISEA), AND METHODS OF USE |
12/06/2000 | EP1056858A1 RECOMBINANT ACTIVE HUMAN ZONA PELLUCIDA PROTEIN 3 (hZP3) |
12/06/2000 | EP1056857A2 Transporter for saccharide-coupled medicaments |
12/06/2000 | EP1056855A2 Exo1 and exo2, exocytotic proteins |
12/06/2000 | EP1056854A2 Protease-activated receptor 4 and uses thereof |
12/06/2000 | EP1056853A2 Human channel-related molecules |
12/06/2000 | EP1056849A1 Human smn-like protein |
12/06/2000 | EP1056848A1 Human protein kinase c inhibitor |
12/06/2000 | EP1056847A2 HUMAN PROTEINS HAVING TRANSMEMBRANE DOMAINS AND DNAs ENCODING THESE PROTEINS |
12/06/2000 | EP1056846A1 Cerebellin-2 related polypeptides and dna coding therefor |
12/06/2000 | EP1056845A1 Immunological methods to modulate myostatin in vertebrate subjects |
12/06/2000 | EP1056844A1 Human receptor gpr14, and a method of finding agonist and antagonist to human and rat gpr14 |
12/06/2000 | EP1056843A1 Therapeutic blockade of icer synthesis to prevent icer-mediated inhibition of immune cell activity |